The Department of Health and Human Services announced that it will be disbursing another $20 billion in CARES Act Provider Relief Funds. Under this Phase 3 General Distribution allocation, physicians that have already received Provider Relief Fund payments may apply for additional funding that considers financial losses and changes in operating expenses caused by the coronavirus. HHS is also announcing that the nation’s behavioral health care providers, including psychiatrists, are now eligible for funding. Previously ineligible physicians, such as those who began practicing in 2020, will also be eligible to apply. Physicians will have from October 5, 2020 through November 6, 2020 to apply for Phase 3 General Distribution funding.
More information is available here.
KMA, LMS to Present “The White Coat Investor” Nov. 12
KMA and the Lexington Medical Society (LMS) will welcome “The White Coat Investor” James Dahle, M.D. for a special virtual presentation on physician personal finance, Thursday, Nov. 12 at 7 p.m. ET. Dr. Dahle is the author of “The White Coat Investor,” which deals with the specific financial issues facing medical students, residents, physicians, dentists, and similar high-income professionals.
Many members expressed an interest in personal finance education during KMA’s 2020 virtual Annual Meeting, which discussed many of the concerns and challenges facing the physician community, particularly in light of the COVID-19 pandemic.
Registration is now available here.
AMA Webinar: “COVID 19 Vaccine Development – What Physicians Need to Know”
The American Medical Association (AMA) is offering a webinar for members, “COVID-19 Vaccine Development—What Physicians Need to Know,” Oct. 7 at 3 p.m. ET. The program is the first in a series that will address the science, evidence and process of vaccine development, regulatory review and what physicians need to know.
Episode 1: FDA Review Process for COVID-19 Vaccine Candidates
Oct. 7, 2 p.m. CT/3 p.m. ET
Host: AMA President, Susan R. Bailey, M.D.
Guest: Peter Marks, M.D., PhD, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration (FDA)
The webinar will discuss a comprehensive overview of the FDA vaccine review process, including what the process looks like for COVID-19 vaccine candidates and the differences between the Emergency Use Authorization (EUA) and Biologic License Application (BLA) pathways.
Registration is available here.
Kentucky Hospital Association COVID-19 Dashboard
The latest update of the Kentucky Hospital Association (KHA) COVID-19 Dashboard is now available here. The dashboard is an effort to provide current information about hospitalizations and ICU bed usage rates due to the novel Coronavirus.